论文部分内容阅读
目的:观察导升明联合氩激光治疗缺血型视网膜中央静脉阻塞的疗效。方法:将92例缺血型视网膜中央静脉阻塞患者随机分为两组,联合导升明组47眼,单纯激光组45眼。两组均行全视网膜光凝治疗,联合导升明组同时加导升明口服3个月,观察两组患者视力及眼底变化情况。结果:两组患者视力变化及眼底情况于3个月时比较,差异均有统计学意义(P<0.05)。结论:氩激光联合导升明治疗缺血型视网膜中央静脉阻塞,可促进出血吸收,改善眼底缺血及视力,防止或减少新生血管的产生。
Objective: To observe the therapeutic effect of Guiding Shengming combined with argon laser in the treatment of ischemic central retinal vein occlusion. Methods: Ninety-two patients with ischemic central retinal vein occlusion were randomly divided into two groups: 47 cases were combined with ascending group and 45 cases were single laser group. The two groups were treated with panretinal photocoagulation, combined with lead-induced group also added dilaterally oral 3 months, visual acuity and fundus changes in both groups were observed. Results: The changes of visual acuity and fundus in both groups were statistically significant at 3 months (P <0.05). Conclusion: Argon laser combined with Dijia Ming treatment of ischemic central retinal vein occlusion, can promote bleeding absorption, improve fundus ischemia and visual acuity, prevent or reduce angiogenesis.